Schrodinger (NASDAQ: SDGR) revenue
Schrodinger reported revenue of $255.9m for fiscal 2025, 23.3% more than in fiscal 2024 ($207.5m). Since fiscal 2019 its revenue has grown by 199.1%, an average growth of 20.0% a year.
Fiscal 2025 is the highest of the 7 fiscal years on record for Schrodinger. The biggest drop was in fiscal 2024, −4.2%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $255.9m | +23.3% | −$166.9m | −65.2% |
| 2024 | $207.5m | −4.2% | −$209.3m | −100.8% |
| 2023 | $216.7m | +19.7% | −$177.4m | −81.9% |
| 2022 | $181.0m | +31.2% | −$146.8m | −81.1% |
| 2021 | $137.9m | +27.6% | −$111.4m | −80.8% |
| 2020 | $108.1m | +26.4% | −$60.9m | −56.4% |
| 2019 | $85.5m | — | −$38.7m | −45.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Schrodinger revenue compared with its sector
By revenue for its latest fiscal year, Schrodinger ranks 232nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Schrodinger, 23.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 230th | Iovance Biotherapeutics | $263.5m | 60.6% |
| 231st | Arvinas | $262.6m | −0.3% |
| 232nd | Schrodinger | $255.9m | 23.3% |
| 233rd | LeMaitre Vascular | $249.6m | 13.5% |
| 234th | Arcus Biosciences | $247.0m | −4.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Schrodinger
- How much revenue did Schrodinger make in fiscal 2025?
- Schrodinger reported revenue of $255.9m for fiscal 2025, compared with $207.5m in fiscal 2024.
- How much has the revenue of Schrodinger grown?
- Between fiscal 2019 and fiscal 2025 it went from $85.5m to $255.9m: 199.1% more, an average growth of 20.0% a year.
- What was the best year for revenue at Schrodinger?
- Of its last 7 fiscal years, fiscal 2025, with $255.9m.
- Where does Schrodinger rank in its sector by revenue?
- It ranks 232nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Schrodinger come from?
- From the annual report (Form 10-K) that Schrodinger files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Schrodinger files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Schrodinger: the Schrodinger page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.